Figures & data
Table 1. List of alu RNA impacting gene regulation and implicated in human diseases
Dewannieux M, Esnault C, Heidmann T. LINE-mediated retrotransposition of marked alu sequences. Nat Genet. 2003;35(1):41–48. Sorek R, Ast G, Graur D. Alu-containing exons are alternatively spliced. Genome Res. 2002;12(7):1060–1067. Walter P, Johnson AE. Signal sequence recognition and protein targeting. Annu Rev Cell Biol. 1994;10(1):87–119. Häsler J, Strub K. Alu elements as regulators of gene expression. Nucleic Acids Res. 2006a;34(19):5491–5497. Häsler J, Strub K. Alu RNP and alu RNA regulate translation initiation in vitro. Nucleic Acids Res. 2006b;34(8):2374–2385. Knebelmann B, Forestier L, Drouot L, et al. Splice-mediated insertion of anAlu sequence in the COL4A3 mRNA causing autosomal recessive Alport syndrome. Hum Mol Genet. 1995;4(4):675–679. Nozu K, Iijima K, Ohysuka Y, et al. Alport syndrome caused by a COL4A5 deletion and exonization of an adjacent AluY. Mol Genet Genomic Med. 2014;2(5):451–453. Pastor T, Talotti G, Lewandowska MA, et al. An Alu-derived intronic splicing enhancer facilitates intronic processing and modulates aberrant splicing in ATM. Nucleic Acids Res. 2009;37(21):7258–7267. Rome C, Loiseau H, Arsaut J, et al. Diversity of Contactin mRNA in Human Brain Tumors. Mol Carcinog. 2006;45(10):774–785. Paz N, Levanon EY, Amariglio N, et al. Altered adenosine-to-inosine RNA editing in human cancer. Genome Res. 2007;17(11):1586–1595. Booy EP, McRae EKS, Koul A, et al. The long non-coding RNA BC200 (BCYRN1) is critical for cancer cell survival and proliferation. Mol Cancer. 2017;16(1):109. Booy EP, Gussakovsky D, Choi T, et al. The noncoding RNA BC200 associates with polysomes to positively regulate mRNA translation in tumor cells. J Biol Chem. 2021;296:100036. Stasenko M, Cybulska P, Feit N, et al. Brain metastasis in epithelial ovarian cancer by BRCA1/2 mutation status. Gynecol Oncol. 2019;154(1):144–149. Thompson ME, Jensen RA, Obermiller PS, et al. Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression. Nat Genet. 1995;9(4):444–450. Sobczak K, Krzyzosiak WJ. Structural determinants of BRCA1 translational regulation. J Biol Chem. 2002;277(19):17349–17358. Haupt S, Vijayakumaran R, Miranda PJ, et al. The role of MDM2 and MDM4 in breast cancer development and prevention. J Mol Cell Biol. 2017;9(1):53–61. Chen LL, Yang L. ALUternative regulation for gene expression. Trends Cell Biol. 2017;27(7):480–490. Hoffman Y, Bublik DR, Pilpel Y, et al. miR-661 downregulates both Mdm2 and Mdm4 to activate p53. Cell Death Differ. 2014;21(2):302–309. Schollen E, Keldermans L, Foulquier F, et al. Characterization of two unusual truncating PMM2 mutations in two CDG-Ia patients. Mol Genet Metab. 2007;90(4):408–413. Ferlini A, Galié N, Merlini L, et al. A novel Alu-like element rearranged in the dystrophin gene causes a splicing mutation in a family with X-linked dilated cardiomyopathy. Am J Hum Genet. 1998;63(2):436–446. Shen S, Lin L, Cai JJ, et al. Widespread establishment and regulatory impact of Alu exons in human genes. Proc Natl Acad Sci U S A. 2011;108(7):2837–2842. Liang D, Wilusz JE. Short intronic repeat sequences facilitate circular RNA production. Genes Dev. 2014;28(20):2233–2247. Hu D, Zhang Y. Circular RNA HIPK3 promotes glioma progression by binding to miR-124-3p. Gene. 2019;690:81–89. Yang C, Zheng J, Liu X, et al. Role of ANKHD1/LINC00346/ZNF655 Feedback Loop in Regulating the Glioma Angiogenesis via Staufen1-Mediated mRNA Decay. Mol Ther Nucleic Acids. 2020;20:866–878. Mitchell GA, Labuda D, Fontaine G, et al. Splice-mediated insertion of an Alu sequence inactivates ornithine aminotransferase: A role for Alu elements in human mutation. Proc Natl Acad Sci U S A. 1991;88(3):815–819. Jourdy Y, Janin A, Fretigny M, et al. Reccurrent F8 intronic deletion found in mild hemophilia a causes alu exonization. Am J Hum Genet. 2018;102(2):199–206. Tan S, Li H, Zhang W, et al. NUDT21 negatively regulates PSMB2 and CXXC5 by alternative polyadenylation and contributes to hepatocellular carcinoma suppression. Oncogene. 2018;37(35):4887–4900. Capshew CR, Dusenbury KL, Hundley HA. Inverted alu dsRNA structures do not affect localization but can alter translation efficiency of human mRNAs independent of RNA editing. Nucleic Acids Res. 2012;40(17):8637–8645. Tomuschat C, O'Donnell AM, Coyle D, et al. NOS-interacting protein (NOSIP) is increased in the colon of patients with Hirschsprungs's disease. J Pediatr Surg. 2017;52(5):772–777. Brasil S, Viecelli HM, Meili D, et al. Pseudoexon exclusion by antisense therapy in 6-pyruvoyl-tetrahydropterin synthase deficiency. Hum Mutat. 2011;32(9):1019–1027. Bonnefoy S, Watson CM, Kernohan KD, et al. Biallelic Mutations in LRRC56, Encoding a Protein Associated with Intraflagellar Transport, Cause Mucociliary Clearance and Laterality Defects. Am J Hum Genet. 2018;103(5):727–739. Kim JS, Chang JW, Park JK, et al. Increased aldehyde reductase expression mediates acquired radioresistance of laryngeal cancer cells via modulating p53. Cancer Biol Ther. 2012;13(8):638–646. Saraei R, Soleimani M, Akbari AAM, et al. The role of XIAP in resistance to TNF-related apoptosis-inducing ligand (TRAIL) in Leukemia. Biomed Pharmacother. 2018;107:1010–1019. Hiraide T, Nakashima M, Ikeda T, et al. Identification of a deep intronic POLR3A variant causing inclusion of a pseudoexon derived from an Alu element in Pol III-related leukodystrophy. J Hum Genet. 2020;65(10):921–925. Gong C, Maquat LE. lncRNAs transactivate STAU1-mediated mRNA decay by duplexing with 3ʹ UTRs via alu elements. Nature. 2011;470(7333):284–290. Bortolin-Cavaille ML, Dance M, Weber M, et al. C19MC microRNAs are processed from introns of large Pol-II, non-protein-coding transcripts. Nucleic Acids Res. 2009;37(10):3464–3473. Zhang Y, Sun M, Chen Y, et al. MiR-519b-3p inhibits the proliferation and invasion in colorectal cancer via modulating the uMtCK/Wnt signaling pathway. Front Pharmacol. 2019b;10:1–9. Bhattacharya A, Jha V, Singhal K, et al. Multiple Alu exonization in 3ʹUTR of a primate specific isoform of CYP20A1 creates a potential miRNA sponge. Genome Biol Evol. 2021;13:evaa233. Oberley LW. Mechanism of the tumor suppressive effect of MnSOD overexpression. Biomed Pharmacother. 2005;59(4):143–148. Stuart JJ, Egry LA, Wong GH, et al. The 3ʹ UTR of human MnSOD mRNA hybridizes to a small cytoplasmic RNA and inhibits gene expression. Biochem Biophys Res Commun. 2000;274(3):641–648. Lazzari E, Mondala PK, Santos ND, et al. Alu-dependent RNA editing of GLI1 promotes malignant regeneration in multiple myeloma. Nat Commun. 2017;8(1):1922. Larsen PA, Lutz MW, Hunnicutt KE, et al. The Alu neurodegeneration hypothesis: A primate-specific mechanism for neuronal transcription noise, mitochondrial dysfunction, and manifestation of neurodegenerative disease. Alzheimers Dement. 2017;13(7):828–838. Pagliarini V, Jolly A, Bielli P, et al. Sam68 binds Alu-rich introns in SMN and promotes pre-mRNA circularization. Nucleic Acids Res. 2020;48(2):633–645 Mameli E, Lepori MB, Chiappe F, et al. Wilson's disease caused by alternative splicing and Alu exonization due to a homozygous 3039-bp deletion spanning from intron 1 to exon 2 of the ATP7B gene. Gene. 2015;569(2):276–279 Kent WJ, Sugnet CW, Furey TS, et al. The Human Genome Browser at UCSC. Genome Res. 2002;12(6):996–1006. Nishikura K. A-to-I editing of coding and non-coding RNAs by ADARs. Nat Rev Mol Cell Biol. 2016;17(2):83–96.